CNS Pharmaceuticals CNSP
NASDAQ CNSP
$4.53 -0.22 (-4.63%)
As of: Oct 23, 2026 · 2:06 PM EDT

CNS Pharmaceuticals (CNSP) Return on Sales [ROS] (2023 - 2024)

Updated

Analysis

CNS Pharmaceuticals (CNSP) Return on Sales [ROS] (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,124.12 Bn 1,092.71 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 634.38 Bn 554.24 Bn 17.30 Bn 24.35%
3 AbbVie 505.39 Bn 478.50 Bn 12.70 Bn 37.86%
4 Merck 357.36 Bn 311.74 Bn 12.21 Bn -3.52%
5 Novartis Ag 290.21 Bn 254.20 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.21 Bn 238.89 Bn 12.86 Bn 20.57%
7 Amgen 237.81 Bn 193.21 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn -133.21%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 28.37%
10 CNS Pharmaceuticals 2.01 Mn -40.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -3,344,201.89%
Dec 31, 2023 -130,535.57%
Sep 30, 2023 -41,048.80%
Jun 30, 2023 -96,950.53%
API Access

CNS Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CNSP&period=max&api_key=YOUR_API_KEY